| 101.43 -0.16 (-0.16%) | 04-19 14:54 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 124.62 |
1-year : | 128.38 |
| Resists | First : | 106.69 |
Second : | 109.91 |
| Pivot price | 105.65 |
|||
| Supports | First : | 101.48 |
Second : | 84.43 |
| MAs | MA(5) : | 102.67 |
MA(20) : | 106.29 |
| MA(100) : | 104.15  |
MA(250) : | 102.99 |
|
| MACD | MACD : | -1.3 |
Signal : | -0.6 |
| %K %D | K(14,3) : | 0.4 |
D(3) : | 0.8 |
| RSI | RSI(14): 27.8 |
|||
| 52-week | High : | 110.58 | Low : | 89.31 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ FXH ] has closed above bottom band by 6.8%. Bollinger Bands are 98.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 103.5 - 104.49 | 104.49 - 105.1 |
| Low: | 99.92 - 101.25 | 101.25 - 102.05 |
| Close: | 100.58 - 102.71 | 102.71 - 104 |
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks that comprise the index. The index is a modified equal-dollar weighted index to objectively identify and select stocks from the Russell 1000® Index in the health care sector that may generate positive alpha relative to traditional passive-style indices through the use of the AlphaDEX® selection methodology.
Mon, 15 Apr 2024
Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)? - Yahoo Canada Shine On
Mon, 01 Apr 2024
(FXH) Proactive Strategies - Stock Traders Daily
Fri, 15 Dec 2023
5 best healthcare sector ETFs - MarketBeat
Wed, 01 Sep 2021
Best Healthcare ETFs To Buy Now - Kiplinger's Personal Finance
Thu, 06 Jun 2019
Health Care Sector Has Many Angles | etf.com - etf.com
Thu, 31 Aug 2017
How United Therapeutics' Remodulin and Tyvaso Are Performing - Market Realist
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|